The fall 2018 Precision Medicine World Conference will be held at Duke, Sept. 24 and 25, at the Washington Duke Inn & Golf Club.
CAGPM wrapped up the inaugural year of the Snyderman Scholars Applied Genomics & Precision Medicine Summer Program on July 25.
For 10 weeks, nine underclassmen from all over the country have been working in Duke labs.
Duke School of Medicine announced its intention to launch the new Duke Genomic Medicine Collaboratory.
With the increasing use of genetic ancestry databases by criminal investigators to identify perpetrators of cold cases, some concern about the privacy of ancestry databases has been raised.
As 3,000 first-year students begin preparing for their Duke career, recent graduate Sarina Madhavan has some advice for them.
Lori Orlando is the PI of an NIH sub-contract for a supplemental proposal to Vanderbilt University’s Electronic MEdical Records and GEnomics (eMERGE) project. The goal of the project is to incorporate MeTree into the electronic health record (EHR) systems at three US sites and the National Health Service in England.
Tim Veldman, Tom Burke, and Geoff Ginsburg, along with Department of Neurology's Danny Laskowitz, Shreyansh Shah and Saurabh Sinha were awarded a grant from the Department of Defense Congressionally Directed Medical Research Program.
Deepak Voora and Geoff Ginsburg were awarded an internal grant from the Translating Duke Health Initiative.
Ricardo Henao was awarded a Subcontract through Vigilant Medical.
Geoff Ginsburg, Ephraim Tsalik, Ricardo Henao, and Chris Woods are authors on this paper on prognostic models for 30-day mortality from sepsis infection.
Geoff Ginsburg was part of a team that investigated the US landscape of research programs in PGx implementation, review current advances and clinical applications of PGx, summarize the obstacles that have hindered PGx implementation, and identify the critical knowledge gaps and possible studies needed to help to address them.
Ginsburg co-authored an overview of precision medicine and its vital stakeholders. Haga along with Duke undergraduate research assistant Ariel Kantor report on their analysis of the number and types of pharmacogenetic tests offered by clinical testing laboratories in the U.S.
Led by researchers from Harvard Medical School and Harvard Pilgrim Health Care Institute, the study reported variation between Medicare contractors and private insurers regarding coverage of testing for cancer treatment.
Several CAGPM staff and faculty co-authored a paper published in Genetics in Medicine on implementation, adoption, and utility of family health history risk assessment in diverse care settings.
Rachel Mills and several other genetic counselors have published examples of pharmacogenetic testing applications across a range of medical specialties.
The CGSU provides the infrastructure and operational excellence to support translational research in genome and implementation sciences.
The laboratory brings together expertise in molecular microbiology with genome sciences to develop next-generation diagnostic tests.
We support biobanking activities including IRB, sample collection, processing, storage, bar-coded chain of custody and e-inventory management.